Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-10

Clinical Trial Update: Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH) [Phase 2]

View source ↗

Summary

Phase 2 trial update for minocycline in aneurysmal subarachnoid hemorrhage is active/not recruiting, focusing on aneurysm, vasospasm, delayed cerebral ischemia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: University of Southern California | Conditions: Aneurysm, Ruptured, Vasospasm, Intracranial | Phase 2 | Status: ACTIVE_NOT_RECRUITING